Cytoreductive surgery explained

Cytoreductive surgery (CRS) is a surgical procedure that aims to reduce the amount of cancer cells in the abdominal cavity for patients with tumors that have spread intraabdominally (peritoneal carcinomatosis). It is often used to treat ovarian cancer but can also be used for other abdominal malignancies.

CRS is often used in combination with hyperthermic intraperitoneal chemotherapy (HIPEC); for some cancer diagnoses it considerably increases life expectancy and reduces the rate of cancer recurrence.

Its main developer was Paul Sugarbaker, who is known for the development of cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy,[1] or HIPEC, a treatment alternately referred to as the Sugarbaker Procedure.[2] [3]

Ovarian cancer

Among patients with stage III epithelial ovarian cancer, the addition of HIPEC to interval cytoreductive surgery resulted in longer recurrence-free survival and overall survival than surgery alone and did not result in higher rates of side effects.[4]

Colorectal cancer

Among colorectal cancer patients with peritoneal carcinomatosis cytoreductive surgery, with the addition of HIPEC can be used to prolong overall survival in patients.[5] In a typical case an incision is made from the sternum down to the pelvis, and cancerous cells are removed. Then heated chemotherapy liquid is poured in to destroy remaining cells. The procedure, which may take 15 hours, is risky, and followed by prolonged recovery.[6]

Notes and References

  1. Neuwirth . Madalyn G. . Alexander . H. Richard . Karakousis . Giorgos C. . Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective . Journal of Gastrointestinal Oncology . February 2016 . 7 . 1 . 18–28 . 10.3978/j.issn.2078-6891.2015.106 . 26941981 . 4754315 .
  2. News: Pollack . Andrew . Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts . The New York Times . 12 August 2011 .
  3. News: Surgeon performs controversial cancer surgery named after him. Wilber. Del Quentin. 2012-11-25. Washington Post. 2018-04-22 .
  4. van Driel . Willemien J. . Koole . Simone N. . Sikorska . Karolina . Schagen van Leeuwen . Jules H. . Schreuder . Henk W.R. . Hermans . Ralph H.M. . de Hingh . Ignace H.J.T. . van der Velden . Jacobus . Arts . Henriëtte J. . Massuger . Leon F.A.G. . Aalbers . Arend G.J. . Verwaal . Victor J. . Kieffer . Jacobien M. . Van de Vijver . Koen K. . van Tinteren . Harm . Aaronson . Neil K. . Sonke . Gabe S. . Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer . New England Journal of Medicine . 18 January 2018 . 378 . 3 . 230–240 . 10.1056/NEJMoa1708618 . 29342393 . 1874/364110 . free . free .
  5. Huang . Chao-Qun . Min . Yao . Wang . Shu-Yi . Yang . Xiao-Jun . Liu . Yang . Xiong . Bin . Yonemura . Yutaka . Li . Yan . Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence . Oncotarget . 15 August 2017 . 8 . 33 . 55657–55683 . 10.18632/oncotarget.17497 . 28903452 . 5589691 .
  6. News: Harcombe . Chloe . Bowel cancer patient issues warning about silent killer . BBC News . 16 June 2024 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Cytoreductive surgery".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.